<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, April 29, 2020 (HealthDay News) — Primary percutaneous coronary intervention (PCI) remains the standard of care for patients with ST-elevation myocardial infarction (STEMI) during the COVID-19 pandemic, according to a consensus statement published online April 20 in the Journal of the American College of Cardiology<\/i>.<\/p>\n
Ehtisham Mahmud, M.D., from the University of California, San Diego, and colleagues provided recommendations for a systematic approach for care of acute myocardial infarction patients during the COVID-19 pandemic. Two major challenges complicate the provision of recommendations for care: cardiovascular manifestations of COVID-19 are complex, and the prevalence of COVID-19 remains unknown.<\/p>\n
The authors address care of these patients by focusing on varied clinical presentations; appropriate personal protective equipment (PPE) for health care workers; the role of the emergency department (ED), emergency medical system, and the cardiac catheterization laboratory (CCL); and regional systems of care for STEMI. For patients at hospitals capable of PCI, primary PCI remains the standard of care when it can be provided in a timely manner, with an expert team fitted with PPE in a dedicated CCL room. At hospitals that are not capable of PCI, or in specific situations where primary PCI cannot be executed or is not deemed the best option, a fibrinolysis-based strategy may be considered.<\/p>\n
“Clinicians should recognize that patients with COVID-19 are inherently complex: a broad differential diagnosis for ST elevations (including COVID-associated myocarditis) should be considered in the ED prior to choosing a reperfusion strategy,” the authors write.<\/p>\n
Several authors disclosed ties to the pharmaceutical and medical device industries.<\/p>\n
Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n